| Literature DB >> 24611112 |
Mirey Karavetian1, Saade Abboud1, Hafez Elzein1, Sarah Haydar1, Nanne de Vries1.
Abstract
THIS STUDY AIMS TO DETERMINE THE EFFECT OF A TRAINED DEDICATED DIETITIAN ON CLINICAL OUTCOMES AMONG LEBANESE HEMODIALYSIS (HD) PATIENTS: and thus demonstrate a viable developing country model. This paper describes the study protocol and baseline data. The study was a multicenter randomized controlled trial with parallel-group design involving 12 HD units: assigned to cluster A (n = 6) or B (n = 6). A total of 570 patients met the inclusion criteria. Patients in cluster A were randomly assigned as per dialysis shift to the following: Dedicated Dietitian (DD) (n = 133) and Existing Practice (EP) (n = 138) protocols. Cluster B patients (n = 299) received Trained Hospital Dietitian (THD) protocol. Dietitians of the DD and THD groups were trained by the research team on Kidney Disease Outcomes Quality Initiative nutrition guidelines. DD protocol included: individualized nutrition education for 2 hours/month/HD patient for 6 months focusing on renal osteodystrophy and using the Trans-theoretical theory for behavioral change. EP protocol included nutrition education given to patients by hospital dietitians who were blinded to the study. The THD protocol included nutrition education to patients given by hospital dietitian as per the training received but within hospital responsibilities, with no set educational protocol or tools. Baseline data revealed that 40% of patients were hyperphosphatemics (> 5.5 mg/dl) with low dietary adherence and knowledge of dietary P restriction in addition to inadequate daily protein intake (58.86%± 33.87% of needs) yet adequate dietary P intake (795.52 ± 366.94 mg/day). Quality of life (QOL) ranged from 48-75% of full health. Baseline differences between the 3 groups revealed significant differences in serum P, malnutrition status, adherence to diet and P chelators and in 2 factors of the QOL: physical and social functioning. The data show room for improvement in the nutritional status of the patients. The NEMO trial may be able to demonstrate a better nutritional management of HD patients.Entities:
Keywords: Hemodialysis; Lebanon; education; nutrition; osteodystrophy
Year: 2014 PMID: 24611112 PMCID: PMC3944148 DOI: 10.4162/nrp.2014.8.1.103
Source DB: PubMed Journal: Nutr Res Pract ISSN: 1976-1457 Impact factor: 1.926
Fig. 1Flow chart of study design
Fig. 2Attrition data of the study
Baseline profile of study sample and groups
Data are expressed in frequencies and parentages.
†Indicates a difference between the groups.
HD, hemodialysis; CVD, cardiovascular disease; HTN, hypertension; PCKD, polycystic kidney disease; Ca * P, calcium - phosphorus product; SBehCh-PB, stages of behavioral change towards phosphate binders; SBehCh-P, stages of behavioral change towards phosphorus restricted diet.
Pearson's chi-square was used to show between group differences of the categorical data. Significance taken at P < 0.05.
Study parameters of the 3 groups
Data are expressed as mean ± SD.
abcValues in the same row with the different superscripts are significantly different at P < 0.05 based on one way ANOVA and Duncan's post hoc test.
BMI, body mass index; pth, parathyroid hormone; KnQ, knowledge questionnaire; DNAQ, dietary non-adherence questionnaire; MIS, malnutrition inflammation score.